(c)

Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Text with EEA relevance) · European Union

the clinical data submitted to the Agency in support of the application, where possible within two months of the marketing authorisation by the Commission;

← art_17__para_2__point_b__text_1 · All articles · art_17__para_2__point_c__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.